1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Breast Cancers: new trials by email Literature Review of Breast Cancers trials Research Report on Breast Cancers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer Pembrolizumab, Deescalation - Breast Cancers, Triple Negative Breast Cancer (TNBC) | Phase 3 | Recruiting | UNICANCER | 2454 | 2025-07-23 | 2026-07-23 |
Breast Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Breast Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
pembrolizumab (1)
UNICANCER (1)
Belgium (1) · France (1)